Liver Transplantation

Article	Citations
Issue Information ‐ Author Checklist	53
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in 3 different European countries	51
Racial and ethnic disparities in extended criteria allograft use for liver transplantation	44
Incidence and risk factors for chronic rejection in pediatric liver transplantation	44
Comparing preservation solutions for static cold storage in donation after circulatory death liver transplantation	44
Machine learning improves post-transplantation HCC recurrence prediction	39
Coproducing a health advocate intervention for pediatric liver transplant recipients using a human-centered design	39
Robotic liver transplantation: University of Modena experience	38
Intraoperative indocyanine green fluorescence imaging to predict early hepatic arterial complications after liver transplantation	35
Sarcopenic obesity: A new predictor of recipient liver regeneration after living donor liver transplantation?	35
Letter to the Editor: Posthepatic-ischemia-reperfusion injury–related AKI: A need for better biomarkers and interventions to mitigate the risk	35
Acute liver failure: Do we have a consensus regarding management?	34
CAQ Corner: Deceased donor selection and management	34
The PRIMER study: Nudging patients with liver disease toward healthier habits, one step at a time	33
Family planning and donor type: Unrecognized benefits of living donor liver transplantation?	33
Three problems, 2 viruses, and 1 man with a vision and voice: Larry Kramer, medical activist	33
CAQ Corner: Psychosocial and ethical considerations in patient selection for liver transplantation	32
Abnormal fibrinolysis identified by viscoelastic tests in relation to clinical outcomes: Last call to harmonize criteria for future studies on promising associations	32
Issue Information ‐ Instructions to Authors	29
Introducing the Certificate of Added Qualification (CAQ) Corner	29
Issue Information	28
Multicenter evaluation of the Quantra with the QStat Cartridge in adult patients undergoing liver transplantation	27
Issue Information ‐ Instructions to Authors	27
Making the best use of testing for blood phosphatidylethanol	27
Digital imaging software versus the “eyeball” method in quantifying steatosis in a liver biopsy	27

Semaglutide is effective in achieving weight loss in liver transplant recipients	27
Issue Information	26
Normothermic regional perfusion in controlled DCD liver procurement: Outcomes of the Swedish national implementation protocol	26
From embedded interprofessional clinics to expanded alcohol-associated liver disease programs	25
Promising role of two‐dimensional shear wave elastography in the prediction of long‐term morbidity and mortality after liver transplantation	25
Assessing hepatic arterial injuries in the setting of normothermic machine perfusion in liver transplantation: A noninvasive approach	25
Outcomes of patients with acute liver failure listed for liver transplantation: A multicenter prospective cohort analysis	25
Geographic variation in utilization of deceased donor livers in the United States in the era of advanced perfusion	25
“But I didn’t drink!”: What to do with discordant phosphatidylethanol results	24
PRO: Is the management of ACLF better in a liver-dedicated ICU?	23
Letter to the Editor: Oncologic optimization of patients with colorectal liver metastatic disease–An ongoing saga	23
PRO: All patients should receive a palliative care consult during LT evaluation	23
Issue Information ‐ Author Checklist	23
Model for End‐Stage Liver Disease/Pediatric End‐Stage Liver Disease exception policy and outcomes in pediatric patients with hepatopulmonary syndrome requiring liver transplantation	21
Letter to the Editor: Monoacylglycerol acyltransferase 1 in fatty liver ischemia-reperfusion injury–Exacerbation or mitigation?	21
Operational tolerance is not always permanent	21
Liver transplantation for pediatric liver malignancies	21
Simplified ischemia-free liver transplantation by providing alternating flow of the portal vein and hepatic artery: Applicability, efficiency, and safety	21
Policy Corner: HCC exception update	20
Candidates for liver transplant evaluated at satellite clinics at a large academic transplant center are less likely to be waitlisted	20
The future of liver transplantation in the United States: Ongoing optimism and concerns with a prescription for change	20
Letter to the Editor: ChatGPT and unknown clinical questions about liver transplantation	20
When worlds collide	19
Weight to go!—Glucagon-like peptide 1 receptor agonists in liver transplant recipients	19
Access and outcomes in liver transplant candidates: How and when we measure is as important as what we measure	19
Erratum	19
Biliary complications following split liver transplantation in adult recipients: a matched pair analysis on single-center experience	18
Issue Information	18
Leveraging a Machine‐Learning Approach to Predict Recurrent Hepatocellular Carcinoma Following Liver Transplantation: A Step in the Right Direction?	18
Low Levels of Hepatocyte‐Specific Methylation in Cell‐Free DNA Are a Strong Negative Predictor for Acute T Cell–Mediated Rejection Requiring Treatment Following Liver Transplantation	18
Those Donor Leucocytes Again? This Time It’s VITT!	18
Integrating Specialist Palliative Care in the Liver Transplantation Evaluation Process: Creating a Multidisciplinary Team Greater Than the Sum of Its Parts?	18
Issue Information ‐ Author Checklist	18
Issue Information	18
Deceased Donor Liver Transplantation from a SARS‐CoV‐2–Positive Donor to a SARS‐CoV‐2–Positive Recipient	18
The impact of human leukocyte antigen mismatch on recipient outcomes in living‐donor liver transplantation	17
	17
Discarded livers tested by normothermic machine perfusion in the VITTAL trial: Secondary end points and 5-year outcomes	17
PRO AI: AI-augmented allocation is in our future—We should invest the necessary resources today	17
Metabolic issues in patients with metabolic dysfunction–associated steatohepatitis (MASH) and their impact on MASH recurrence following liver transplantation: A narrative review	17
CON: Patients with acute-on-chronic liver failure should not be offered MELD exception points	17
Bariatric surgery post-liver transplantation: A Belgian nationwide study	17
Decompensated cirrhosis but low MELD – should we wait or refer for liver transplantation?	17
Procurement Liver Biopsies: More Scrutiny May Yield More Opportunities	16
A new tool to predict future liver allograft dysfunction?	16
Mapping out a Medication Adherence Promotion System (MAPS): Can it reduce graft rejection in pediatric liver transplantation?	16
A survey of national practice patterns of HCC surveillance for patients with Fontan-associated liver disease: A call to action	16
Issue Information	16
Cannabis and liver transplant: We need to chill, man	16
Lack of progress in cancer-related outcomes after liver transplantation: Mitigating risk and identifying future needs to move this needle	16

Effect of Acuity Circles Allocation Policy on Local Use of Donation After Circulatory Death Donor Livers	15
In memoriam: Ruud A.F. Krom, MD, PhD (1941–2024)	15
Caregivers’ and providers’ perspectives of social and medical care after pediatric liver transplant: Results from the multicenter SOCIAL-Tx study	15
Letter to the Editor: Does therapeutic plasma exchange really have a role in the treatment of hepatocellular carcinoma?	15
Clinical outcomes of patients with Liver Imaging Reporting and Data System 3 or Liver Imaging Reporting and Data System 4 observations in patients with cirrhosis: A systematic review	15
Outcomes using steatotic liver grafts: Will machines score the final goal?	15
Association of psychosocial risk factors and liver transplant evaluation outcomes in metabolic dysfunction–associated steatotic liver disease	15
Looking for literal improvement in liver transplant outcomes	15
Turning the Tide on Hepatitis C Virus–Related Liver Transplantation: The Return on Investment in Hepatitis C Virus Treatment in Australia and New Zealand	15
Lung cancer screening using low-dose CT and FDG-PET in liver transplant recipients	15
Reply: Redo hepatic artery reconstruction for thrombosis without retransplantation in 1355 adult living donor liver transplantations	15
Navigating the road to liver transplantation equity	14
Living donor liver transplantation in the United States for alcohol-associated liver disease and nonalcoholic steatohepatitis: An evaluation in the current era	14
The Role of Psychosocial Screening Tools in the Evaluation of Transplantation Patients With Alcohol‐Related Liver Disease	14
CAQ Corner: Liver transplantation for rare hepatobiliary malignancies	14
Issue Information ‐ Author Checklist	14
Psychosocial Assessment Rather Than Severity of Liver Failure Dominates Selection for Liver Transplantation in Patients With Alcohol‐Related Liver Disease	13
Issue Information ‐ Instructions to Authors	13
Issue Information	13
Reply: ChatGPT and unknown clinical questions about liver transplantation	12
Priority for kidney after liver transplantation: A safety net for all?	12
Abdominal aortic calcification on routine preoperative computed tomography—A novel cardiovascular risk prediction tool in liver transplant patients	12
Building a better mouse trap in liver retransplantation risk prediction: Is reSOFT the end or the beginning?	12
Postoperative heartbreak: Takotsubo cardiomyopathy following liver transplantation	12
Standardized upfront Glissonean approach and liver hanging maneuver reduces bile leakage from the hepatic hilum in living donors	12
Letter to the Editor: Normothermic regional perfusion in controlled DCD liver procurement: Comparable outcomes to DBD liver transplantation in three different European countries	12
Pharmacokinetic and pharmacodynamic considerations of antibiotics and antifungals in liver transplantation recipients	12
Machine perfusion strategies in liver transplantation: A systematic review, pairwise, and network meta-analysis of randomized controlled trials	12
Long‐term quality of life of living liver donors: A Japanese nationwide survey	12
Reply: Does the utilization of machine perfusion require a boundary for livers donated after circulatory death?	12
Reply: Methodological considerations for predicting HCC recurrence after liver transplantation	12
HepB-CpG vaccination: An alternate strategy to life long antiviral therapy in patients transplanted for chronic Hepatitis B	12
Inhibition of SK2 and ER stress ameliorated inflammation and apoptosis in liver ischemia-reperfusion injury	11
Issue Information	11
Erratum: Living donor liver transplantation with a left trisection plus caudate lobe graft	11
Bacterascites confers poor patient prognosis beyond MELD prediction	11
“Age ain’t nothing but a number”: Advanced perfusion is the key to increasing the usability of older DCD donor livers	11
Causes of variability in listing and access to liver transplantation for critically ill patients with cirrhosis: Acknowledging the elephant in the room	11
Policy Corner: Polycystic liver disease MELD exception update	11
Do not underestimate the impact of hepatic hydrothorax on survival before and after liver transplant	11
Impact of implementation of national liver review board on liver allocation among patients with primary sclerosing cholangitis	11
No Salvation Without Regeneration	11
Lung function decline is mitigated following liver transplantation in people with cystic fibrosis: A retrospective cohort study	11
Factors associated with receiving a liver transplant from deceased donors located far from the transplant hospital	11
Anatomical classification and clinical outcomes of biliary strictures in living donor liver transplantation using right liver grafts	11
Deceased Donor Liver Transplantation After Radioembolization for Hepatocellular Carcinoma and Portal Vein Tumoral Thrombosis: A Pilot Study	10
Evaluating Outcomes Related to Donor and Recipient Metabolic Environment: Macrosteatotic Allografts and Nonalcoholic Steatohepatitis	10
Waitlist Priority for Patients with Acute‐on‐Chronic Liver Failure: Not Just Horseplay	10
Utility of scores to predict alcohol use after liver transplant: Take them with a grain of salt	10
Initial outcome of external biliary drainage in living donor liver transplantation with pure laparoscopic donor hepatectomy	10
Issue Information	10
Management of portal vein thrombosis in liver transplant candidates	10
Neighborhood poverty is associated with failure to be waitlisted and death during liver transplantation evaluation	10
Viability assessment and transplantation of fatty liver grafts using end‐ischemic normothermic machine perfusion	10
Blood Pressure Variability Early After Liver Transplantation Predicts Long‐Term Mortality	9
Assessment of Deceased Brain Dead Donor Liver Grafts via Normothermic Machine Perfusion: Lactate Clearance Time Threshold Can Be Safely Extended to 6 Hours	9
Survival benefit of liver transplantation utilizing marginal donor organ according to ABO blood type	9
Preservation of coagulation function by normothermic machine perfusion in liver transplant as evidenced by thromboelastography parameters	9
Letter to the Editor: Impact of long-term continuous terlipressin infusion on the liver transplant waitlist in an Australian cohort	9
A New Hope for a New Year	9
Informatics-driven solutions for optimal care delivery in liver transplantation	9
Biomarkers of Operational Tolerance After Liver Transplantation: Are We There Yet?	9
Language Accessibility of Liver Transplantation Center Websites	8
Recurrence of autoimmune liver diseases after liver transplantation: Review and expert opinion statement	8
Erratum	8
Declining a Split‐Liver Offer Can Be Hazardous to Your Health	8
CAQ Corner: Technical considerations in liver transplantation (101 for hepatologists)	8
Letter to the Editor: Is CAD-LT score as a predictor of coronary artery disease following liver transplantation?	8
Feasibility, safety, and outcome of second-line nivolumab/bevacizumab in liver transplant patients with recurrent hepatocellular carcinoma	8
Lack of differences in outcomes between 3 immunosuppression protocols in the first year after pediatric liver transplantation: A multicenter study	8
Transforming the logistics of liver transplantation with normothermic machine perfusion: Clinical impact versus cost	8
Reply: We still need to deal with antibody-mediated rejection in living donor liver transplantation	8
Reply	8
No transplant candidate left behind	8
Letter to the Editor: Robust clinician relationships must be the bedrock for future innovations in integrated alcohol-associated liver disease care	8
The fundamentals of sex‐based disparity in liver transplantation: Understanding can lead to change	8
Elevated fractional donor‐derived cell‐free DNA during subclinical graft injury after liver transplantation	8
Utility of glucagon-like peptide 1 receptor agonists as anti-obesity medications in liver transplant recipients	8
Low‐dose aspirin, rejection, and thrombosis: Is it the Wonder Drug® of liver transplantation?	8
Issue Information	8

Incidence and outcomes of liver retransplantation using living donor allografts in the US	8
Financial burden of cirrhosis is significantly reduced after liver transplantation	8
Liver transplantation for acute-on-chronic liver failure due to carnitine palmitoyl transferase (CPT) 1A deficiency	7
Second thoughts about second opinions for liver transplantation	7
Terlipressin plus albumin in patients with HRS listed for liver transplant: Treat early and avoid RRT	7
Long‐term Outcomes of Pediatric Living Versus Deceased Donor Liver Transplantation Recipients: A Systematic Review and Meta‐analysis	7
Reduced Discard Rates of Split Liver Grafts by Having a Combined Adult‐Pediatric LT Program	7
Pediatric Living Donor Liver Transplantation Outcomes—Is it Time for Outcome Optimization of Technical Aspects of Transplantation Using Learning Networks?	7
Does hepatectomy technique matter?	7
Portopulmonary hypertension: May we agree to disagree?	7
Use and outcomes of hepatitis B virus–positive grafts in orthotopic liver transplantation in the United States from 1999 to 2021	7
Fellows’ Corner	7
Barriers to liver transplant referral in safety net settings: A national provider survey	7
Letter to the Editor: Plasma exchange for alcohol-associated liver disease as a bridge to liver transplantation—A call to expand its adaptation in Japan	7
Enhancing the prognostic accuracy of the RETREAT score with AFP-L3 and DCP tumor markers	7
Reply	7
Speaking of the (Barely Legal) Elephant in the Room: Herbal or Dietary Supplement–Related Acute Liver Failure	7
Policy Corner: Cholangitis exception update	7
Transplant selection simulation: Liver transplantation for alcohol-associated hepatitis	7
Optimizing the mouse orthotopic liver transplantation model: Learning curve, technical enhancements, and keys to success	7
Untangling the web of waitlist dropout in HCC	7
Issue Information ‐ Instructions to Authors	7
The Prediction of In‐Hospital Mortality in Decompensated Cirrhosis with Acute‐on‐Chronic Liver Failure	7
Geospatial analysis of liver donation after death by drug intoxication	7
Issue Information ‐ Instructions to Authors	7
Letter to the Editor: Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	7
Locoregional therapy for colorectal liver metastases awaiting transplantation: Balancing tumor control with liver toxicity	7
Every last detail—Managing hepatic artery thrombosis and stenosis in a time of organ scarcity	6
Offer Acceptance Patterns for Liver Donors Aged 70 and Older	6
Telemedicine in Hepatology: Current Applications and Future Directions	6
Potential strategies in porcine liver xenotransplantation: A bridge to allotransplantation and beyond	6
Long‐term follow‐up of living liver donors	6
Validation of MELD 3.0 scoring system in East Asian patients with cirrhosis awaiting liver transplantation	6
Combination of Donor Anthropometrics With Recipient Imaging to Improve Matching in Liver Transplantation	6
Erratum: Development and validation of a REcurrent Liver cAncer Prediction ScorE (RELAPSE) following liver transplantation in patients with hepatocellular carcinoma: Analysis of the US multicenter HCC	6
Reply: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	6
Third dose of coronavirus disease 2019 vaccination in liver transplantation recipients	6
Reduction of hepatectomy times in Dutch organ procurement teams	6
Impact of Race‐Adjusted Glomerular Filtration Rate Estimation on Eligibility for Simultaneous Liver‐Kidney Transplantation	6
Letter to the Editor: The urgent need for consensus around organ donation after assisted dying	6
Quantitative methods for optimizing patient outcomes in liver transplantation	6
Low‐dose aspirin confers protection against acute cellular allograft rejection after primary liver transplantation	6
Maximizing outcomes by donor-recipient age matching in liver transplantation	6
Deep learning and the future of the Model for End‐Stage Liver Disease–sodium score	6
Issue Information ‐ Instructions to Authors	6
Combining radiomics and imaging biomarkers with clinical variables for the prediction of HCC recurrence after liver transplantation	6
Prognostic significance of acute kidney injury stage 1B in hospitalized patients with cirrhosis: A US nationwide study	6
The impact of alcohol-associated liver disease on famous athletes who received liver transplants	6
Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety survey	6
Reply: Coronary CT angiography for predicting early post-liver transplant MACE: Paradigm shift or part of the calculus?	6
Creation of a new VA liver transplantation center increased access and retained care within the Veterans Health Administration	6
Hospital readmission for acute kidney injury is independently associated with de novo end-stage renal disease after liver transplantation	6
“Winning the peace” against obesity in recipients of liver transplant	6
Anonymity: What does it mean and why is it important to anonymous living liver donors?	6
Utilization of fibrotic HCV-viremic grafts in liver transplantation: An emerging opportunity or a step too far?	5
The incidence of severe complications in liver donation from living donors: Real-world data in the era of minimally invasive surgery	5
MRI-serum–based score accurately identifies patients undergoing liver transplant without rejection avoiding the need for liver biopsy: A multisite European study	5
A scoping review of nonmedical barriers to living donor liver transplant	5
Letter to the Editor: Induction therapy in pediatric liver transplants affects outcomes	5
Salvaging the fatty liver for transplant: is short duration NMP enough?	5
CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis	5
Early steroids after pediatric liver transplantation protect against T-cell–mediated rejection: Results from the ChilSFree study	5
Issue Information ‐ Author Checklist	5
Mending the Model for End‐Stage Liver Disease: An in‐depth review of the past, present, and future portopulmonary hypertension Model for End‐Stage Liver Disease exception	5
Use of Livers With Fibrosis Based on Donor Hospital Biopsy: Missed Opportunities?	5
Outcomes of pediatric candidates for liver retransplantation in the modern era: Strategies are needed to avoid waitlist mortality in the United States	5
A Modified liver donor risk index for pediatric liver transplant recipients	5
Letter to the Editor: True effect of splenic artery ligation warrants evaluation through robust statistical analyses	5
Is stenting really necessary during primary angioplasty for portal vein stenosis after pediatric liver transplantation?	5
Efficiency of machine perfusion in pediatric liver transplantation	5
Fluorescence confocal microscopy on liver specimens for full digitization of transplant pathology	5
Liver transplantation in tight junction protein‐2 deficiency associated liver disease	5
Issue Information	5
Evaluating the outcomes of donor-recipient age differences in young adults undergoing liver transplantation	5
Incidence and risk factors for skin cancer in liver transplant recipients: A systematic review	5
A snapshot of challenges and opportunities faced by the scientific workforce in liver transplantation—a survey of the International Liver Transplantation Society (ILTS)	5
Associations of sarcopenia with graft failure and mortality in patients undergoing living donor liver transplantation	5
Controversies in terlipressin and transplantation in the United States: How do we MELD the two?	5
Low Immunoglobulin G Antibody Levels Against Severe Acute Respiratory Disease Coronavirus 2 After 2‐Dose Vaccination Among Liver Transplantation Recipients	5
Proposing a Framework to Assess the Methodological Quality of Prognostic Models	5
Outcome of split‐liver transplantation from pediatric donors weighing 25 kg or less	5
Issue Information	5
Issue Information ‐ Author Checklist	5
Acute cellular rejection in liver transplantation recipients following coronavirus disease 2019 vaccination	4
PRO MELD: MELD is the best method of prioritization for liver transplantation	4
New‐Onset Antibodies to Platelet Factor 4 Following Liver Transplantation From a Donor With Vaccine‐Induced Thrombotic Thrombocytopenia	4
Less salt and more water for children—not just dietary, but transplant management too	4
Expanding the indication of living donor liver transplantation to recipients with PVT: Clinical advances and ongoing challenges	4
Introducing the Liver Transplant Policy Corner	4
Postliver transplant acute cardiomyopathy: Role of prospective cardiac evaluation in immediate posttransplant period	4
Statement of Ownership	4
Progress and challenges in assessing allograft health in liver transplantation	4
Waitlist and posttransplant outcomes of pregnancy-related acute liver failure in the United States	4
Immunosuppression minimization is safe and associated with good long-term success in pediatric recipients of liver transplant	4
Reply: Development of a portable abdominal normothermic regional perfusion (A-NRP) program in the United States	4